Medimynds

Company Overview

Snapshot

Founded in July 2025, Medimynds operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing its core digital platform.

Business overview

Medimynds develops Admynds, a digital platform designed to enhance medication adherence by enabling healthcare providers to conduct patient-tailored dialogues during medical encounters. The system customizes communication based on a patient's socio-psychological profile and integrates seamlessly into existing provider workflows for both in-person and virtual care. Medimynds aims to improve patient outcomes and adherence, reduce the time providers spend on psychological assessments, and support value-based care goals for health systems within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Engagement.

Company Intelligence Q&A

When was Medimynds founded?

Medimynds was founded in July 2025.

What is the primary focus of Medimynds' product?

Medimynds' product, Admynds, focuses on improving medication adherence through personalized provider messaging and patient-tailored dialogues during medical encounters.

What stage is Medimynds currently in?

Medimynds is currently in the Pre-Funding stage.

How does Medimynds' platform integrate into healthcare workflows?

The Medimynds platform is designed to fit into provider workflows across both in-person and virtual care settings, tailoring communication to a patient's socio-psychological profile.

What problem does Medimynds aim to solve for healthcare providers?

Medimynds aims to help healthcare providers improve medication adherence and related patient outcomes, while also reducing the time spent on psychological assessment and supporting value-based care goals for health systems.